Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin; medicine for internal use, such as digestive and herbal medicines; oral medicines comprising gastrointestinal medicines, herbal medicines, and supplements; non-prescription medicines; and beauty counters that provide beauty and health services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. Rohto Pharmaceutical Co.,Ltd. was founded in 1899 and is headquartered in Osaka, Japan.
Revenue of Rohto Pharmaceutical Co.,Ltd. (4527.T)
Revenue in 2023 (TTM): $1.8 B
According to Rohto Pharmaceutical Co.,Ltd.'s latest financial reports the company's current revenue (TTM) is $1.8 B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of Rohto Pharmaceutical Co.,Ltd.
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $1.8 B | $1.03 B | $324.22 M | $275.53 M | $205.3 M |
| 2022 | $1.58 B | $911.98 M | $287.36 M | $227.56 M | $175.05 M |
| 2021 | $1.32 B | $773.07 M | $253.27 M | $185.51 M | $140.21 M |
| 2020 | $1.2 B | $708.28 M | $211.2 M | $152.68 M | $111.11 M |
| 2019 | $1.25 B | $758.14 M | $194.19 M | $144.21 M | $102.27 M |
| 2018 | $1.22 B | $727.51 M | $169.36 M | $108.17 M | $65.03 M |
| 2017 | $1.14 B | $670.6 M | $165.27 M | $111.62 M | $61.65 M |
| 2016 | $1.03 B | $606.2 M | $146.13 M | $97.9 M | $66.44 M |
| 2015 | $1.1 B | $658.51 M | $145.68 M | $94.92 M | $60.38 M |
| 2014 | $1.01 B | $601.25 M | $136.46 M | $91.26 M | $57.28 M |
| 2013 | $956.19 M | $571.78 M | $154.75 M | $96.88 M | $59.38 M |
| 2012 | $853.88 M | $503.53 M | $135.76 M | $90.45 M | $53.67 M |
| 2011 | $799.18 M | $467.83 M | $198.04 M | $93.49 M | $54.31 M |
| 2010 | $764.93 M | $450.87 M | $191 M | $89.13 M | $52.87 M |
| 2009 | $752.77 M | $443.19 M | $189.93 M | $82.37 M | $51.55 M |
| 2008 | $733.99 M | $432.71 M | $183.05 M | $61.35 M | $40.74 M |
| 2007 | $718.1 M | $429.27 M | $181.53 M | $82.08 M | $49.94 M |